Brain Imaging Reveals Two Distinct Biological Subtypes of Autism

Researchers have identified two biologically distinct subtypes of autism, a discovery that challenges the traditional view of the condition as a singular spectrum. By analyzing functional brain connectivity in nearly 1,000 human subjects and comparing these patterns against 20 genetically engineered mouse models, the international team identified two unique neurological signatures: 'hyperconnectivity,' characterized by excessive communication between brain regions, and 'hypoconnectivity,' marked by reduced neural interaction.

The study, led by the Istituto Italiano di Tecnologia and the Child Mind Institute, represents a significant leap toward precision medicine in neurodevelopmental research. By linking these connectivity patterns to specific molecular mechanisms—synaptic pathways for hypoconnectivity and immune-related systems for hyperconnectivity—scientists have provided a biological basis for the clinical variability long observed in autism patients. This research effectively bridges the gap between complex human imaging data and the underlying cellular processes that drive these differences.

This breakthrough is critical because it suggests that future diagnostic and therapeutic approaches could be tailored to an individual’s specific biological profile. Currently, autism treatment is often generalized, but these findings indicate that patients may respond differently to interventions depending on whether their condition is driven by synaptic or immune-related pathways. By moving away from a 'one-size-fits-all' model, this research paves the way for more targeted, effective clinical care that addresses the root biological causes of autism rather than just its behavioral symptoms.